If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM&G Regulatory News (MNG)

Share Price Information for M&G (MNG)

Share Price is delayed by 15 minutes
Get Live Data
342.70    2.70 (0.79%)
Bid:
342.60
Ask:
342.80
Spread: 0.20 (0.058%)
Market Cap: £8.16b
MNG Live PriceLast checked at - London Stock Exchange

Intraday M&G Share Chart

Director/PDMR Shareholding

15 May 2025 13:00

RNS Number : 8624I
M&G PLC
15 May 2025
 

M&G plc NEWS RELEASE15 May 2025

M&G plc

Notification of transactions by Persons Discharging Managerial Responsibilities (PDMRs)

M&G plc (the 'Company') announces changes to the interests in the Company for certain PDMRs.

On 14 May 2025, further to the Company's interim dividend payment on 9 May 2025, dividend equivalent shares that had accrued on certain vested deferred incentive or long term incentive share plan awards were released to the PDMRs set out below. The PDMRs retained the balance of shares after deductions to cover tax liabilities and sale costs.

In addition, the Company was informed on 14 May 2025 of changes to the interests of Benoît Macé, following the reinvestment of the interim dividend on a personal shareholding.

The notifications below, made in accordance with the requirements of the Market Abuse Regulation, provide further detail.

Contact

Christopher Smyth, Director of Secretariat - 020 8162 0527

Sharna Ludlow, Head of Share Plans and Share Registration - 020 8162 0611

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Clive Bolton

2

Reason for the notification

a)

Position/status

Chief Executive Officer, M&G Life

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

M&G plc 

b)

LEI

254900TWUJUQ44TQJY84

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 5 pence each

 

 

GB00BKFB1C65

b)

Nature of the transaction

Release of dividend equivalent shares under the M&G Performance Share Plan

 

c)

Price(s) and volume(s)

Price (s)

Volume (s)

Nil

6,684

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

6,684

 

Nil

e)

Date of the transaction

2025-05-14

f)

Place of the transaction

Outside a trading venue

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 5 pence each

 

 

GB00BKFB1C65

 b) 

Nature of the transaction

Sale of shares to cover applicable withholding tax and other deductions arising on release of dividend equivalent shares under the M&G Performance Share Plan

 

c)

Price(s) and volume(s)

Price (s)

Volume (s)

£2.1804

3,151

Aggregated information

 

-Aggregated volume

 

-Price

 

 

3,151

 

£2.1804

Date of the transaction

2025-05-14

Place of the transaction

XLON

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Chris Cochrane

2

Reason for the notification

a)

Position/status

Chief Information Technology Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

M&G plc 

b)

LEI

254900TWUJUQ44TQJY84

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 5 pence each

 

 

GB00BKFB1C65

b)

Nature of the transaction

Release of dividend equivalent shares under the:

a) M&G Deferred Incentive Plan

b) M&G Performance Share Plan

 

c)

Price(s) and volume(s)

Item

Price (s)

Volume (s)

a.

Nil

2,079

b.

Nil

6,367

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

8,446

 

Nil

e)

Date of the transaction

2025-05-14

f)

Place of the transaction

Outside a trading venue

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 5 pence each

 

 

GB00BKFB1C65

 b) 

Nature of the transaction

Sale of shares to cover applicable withholding tax and other deductions arising on release of dividend equivalent shares under the:

a) M&G Deferred Incentive Plan

b) M&G Performance Share Plan

 

c)

Price(s) and volume(s)

Item

Price (s)

Volume (s)

a)

£2.1804

989

b)

£2.1804

3,002

Aggregated information

 

-Aggregated volume

 

-Price

 

 

3,991

 

£2.1804

Date of the transaction

2025-05-14

Place of the transaction

XLON

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Matthew Howells

2

Reason for the notification

a)

Position/status

Chief People Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

M&G plc 

b)

LEI

254900TWUJUQ44TQJY84

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 5 pence each

 

 

GB00BKFB1C65

b)

Nature of the transaction

Release of dividend equivalent shares under the M&G Deferred Incentive Plan

 

c)

Price(s) and volume(s)

Price (s)

Volume (s)

Nil

4,737

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

4,737

 

Nil

e)

Date of the transaction

2025-05-14

f)

Place of the transaction

Outside a trading venue

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 5 pence each

 

 

GB00BKFB1C65

 b) 

Nature of the transaction

Sale of shares to cover applicable withholding tax and other deductions arising on release of dividend equivalent shares under the M&G Deferred Incentive Plan

 

c)

Price(s) and volume(s)

Price (s)

Volume (s)

£2.1804

2,238

Aggregated information

 

-Aggregated volume

 

-Price

 

 

2,238

 

£2.1804

Date of the transaction

2025-05-14

Place of the transaction

XLON

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Benoît Macé

2

Reason for the notification

a)

Position/status

Chief Strategy & Transformation Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

M&G plc 

b)

LEI

254900TWUJUQ44TQJY84

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 5 pence each

 

 

GB00BKFB1C65

b) 

Nature of the transaction

Acquisition of shares through reinvested dividends on a personal shareholding

 

c)

Price(s) and volume(s)

Price (s)

Volume (s)

£2.186

7,609

Aggregated information

 

-Aggregated volume

 

-Price

 

 

7,609

 

£2.186

Date of the transaction

2025-05-13

Place of the transaction

XLON

 

 

 

 

LEI: 254900TWUJUQ44TQJY84

Classification: 2.2 Information disclosed under article 19 of the Market Abuse Regulation.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSFEFFIEISEFI
Date   Source Headline
25th Feb 20262:09 pmRNSForm 8.3 - SPIRE HEALTHCARE GROUP PLC
24th Feb 202611:56 amRNSForm 8.3 - SPIRE HEALTHCARE GROUP PLC
24th Feb 20267:00 amRNSHolding(s) in Company
23rd Feb 202611:37 amRNSForm 8.3 - SPIRE HEALTHCARE GROUP PLC
20th Feb 20265:40 pmRNSHolding(s) in Company
19th Feb 20261:29 pmRNSForm 8.3 Spire Healthcare Group plc
18th Feb 202611:48 amRNSForm 8.3 Spire Healthcare Group plc
17th Feb 202610:47 amRNSForm 8.3 - Spire Healthcare Group Plc
16th Feb 202611:00 amRNSForm 8.3 SPIRE HEALTHCARE GROUP PLC
6th Feb 202612:44 pmRNSForm 8.3 - Beazley Plc
5th Feb 20262:55 pmRNSForm 8.3 BEAZLEY PLC
2nd Feb 202610:30 amRNSTotal Voting Rights
29th Jan 20261:56 pmRNSForm 8.3 - THE BRITISH LAND COMPANY PLC
27th Jan 20261:48 pmRNSForm 8.3 - Beazley Plc
27th Jan 20268:10 amRNSM&G’s response to Leasehold Reform Bill
21st Jan 20262:47 pmRNSForm 8.3 - BEAZLEY PLC
20th Jan 20261:45 pmRNSForm 8.3 - BEAZLEY PLC
15th Jan 20261:59 pmRNSForm 8.3 - OXFORD BIOMEDICA PLC
13th Jan 20263:45 pmRNSDirector/PDMR Shareholding
13th Jan 20263:30 pmRNSHolding(s) in Company
13th Jan 20267:00 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSHolding(s) in Company
9th Jan 20267:05 amRNSHolding(s) in Company
9th Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 202610:30 amRNSTotal Voting Rights
22nd Dec 20251:30 pmRNSDirector/PDMR Shareholding
22nd Dec 20251:30 pmRNSDirector/PDMR Shareholding
12th Dec 202511:26 amRNSForm 8.3 - UNITE GROUP PLC
10th Dec 20253:45 pmRNSDirector/PDMR Shareholding
4th Dec 202510:48 amRNSForm 8.3 (Spire Healthcare Group plc)
4th Dec 202510:47 amRNSForm 8.3 (Unite Group plc, The)
3rd Dec 20255:11 pmRNSHolding(s) in Company
2nd Dec 202511:32 amRNSForm 8.3 Spire Healthcare Group plc
2nd Dec 202511:31 amRNSForm 8.3 (Unite Group plc, The)
1st Dec 20251:42 pmRNSForm 8.3 - SPIRE HEALTHCARE GROUP PLC
1st Dec 202510:00 amRNSDirector/PDMR Shareholding
1st Dec 20259:45 amRNSTotal Voting Rights
28th Nov 20251:14 pmRNSForm 8.3 - UNITE GROUP PLC
26th Nov 202511:57 amRNSForm 8.3 SPIRE HEALTHCARE GROUP PLC
26th Nov 202511:57 amRNSForm 8.3 (Unite Group plc, The)
24th Nov 20253:45 pmRNSHolding(s) in Company
24th Nov 20257:06 amRNSLife insurance stress test
21st Nov 20253:00 pmRNSHolding(s) in Company
17th Nov 20252:12 pmRNSForm 8.3 - UNITE GROUP PLC
17th Nov 202510:00 amRNSHolding(s) in Company
14th Nov 202511:36 amRNSForm 8.3 - SPIRE HEALTHCARE GROUP PLC
13th Nov 20254:59 pmRNSHolding(s) in Company
13th Nov 202510:15 amRNSDirector/PDMR Shareholding
13th Nov 202510:00 amRNSHolding(s) in Company
12th Nov 202511:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.